Locally Advanced Non-Small Cell Lung Cancer

DBCOND0039376Lung DiseasesRespiratory and mediastinal neoplasms malignant and unspecified

Locally Advanced Non-Small Cell Lung Cancer is the indication for 14 drugs in DrugBank. It is covered by 32 curated, structured indications.

Also known as
locally advanced Non small cell lung cancer · Locally Advanced Non Small Cell Lung Cancer (NSCLC)* · Locally Advanced Lung Non-Small Cell Carcinoma · Locally Advanced NSCLC · Locally Advanced Non Small Cell Lung Cancer (NSCLC)
Classified under
Indicated drugs

What you can answer from here — as of October 26, 2026

14Indicated drugsWith each drug's targets and mechanism
Listed above
32Structured indicationsPopulation, line of therapy, route and combination as fields, not prose
Sign in
67Clinical trialsPhase, status and sponsor resolved per trial
Sign in

Which approved drugs for Locally Advanced Non-Small Cell Lung Cancer share a target, and which companies have late-stage candidates against it?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In